COVID‐19: a pandemic experience that illuminates potential reforms to health research. Issue 11 (19th October 2020)

• Record Type: Journal Article
• Authors: Kozlowski, Hannah N; Farkouh, Michael E; Irwin, Meredith S; Radvanyi, Laszlo G; Schimmer, Aaron D; Tabori, Uri; Rosenblum, Norman D
• Is Part Of: EMBO molecular medicine. Volume 12:Issue 11(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-10-19
• Subjects: Molecular biology -- Periodicals; Medical genetics -- Periodicals; Pathology, Molecular -- Periodicals; 616.04205
• DOI: 10.15252/emmm.202013278
• Languages: English
• ISSNs: 1757-4676

Abstract

Abstract : COVID‐19 has halted research around the globe and forced researchers out of their laboratories. Non‐emergency medical appointments were canceled. Ongoing clinical trials were challenged to create new modes of operation while public pressure mounted to find therapeutic options against COVID‐19. Yet, the inability to conduct research during COVID‐19 was overcome with cooperation, resource sharing, and compassion, which provides important lessons on how to improve health related research as we enter a new normal. Abstract : The COVID‐19 crisis necessitates and unprecedented level off cooperation and sharing in biomedical research. It should inspire science policies and funding post‐COVID to help drive forward Open Science.